Understanding the Impact of the Specialty Pharmacist on Quality and Effective Medication Management: Providing Individualized Care in Rheumatoid Arthritis

This activity is supported by an educational grant from Genentech.

Understanding the Impact of the Specialty Pharmacist on Quality and Effective Medication Management: Providing Individualized Care in Rheumatoid Arthritis

Susan P. Bruce, PharmD, BCPS

Associate Dean, Pharmacy Education and Interprofessional Studies

Chair and Professor, Pharmacy Practice Northeast

Ohio Medical University

Rootstown, Ohio

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose.

Faculty

Susan P. Bruce, PharmD, BCPS

Pharmacy Times Office of Continuing Professional Education Planning Staff—David Heckard; Maryjo Dixon, RPh; Beatriz Mitrzyk, PharmD; Donna Fausak; and Nathalie Harden

Specialty Pharmacy Times Editorial Staff—Davy James

An anonymous peer reviewer was part of the content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Objectives

After participating in this activity, participants should be able to:

• Determine current and emerging therapies used to slow disease progression in patients with rheumatoid arthritis (RA).
• Analyze the rationale for beginning RA therapies early.
• Individualize RA therapies based on a patient disease assessment.
• Identify solutions to overcome patient specific barriers to RA therapy adherence.

Target audience: Pharmacists

Type of activity: Application

Release date: June 8, 2015

Expiration date: June 8, 2016

Estimated time to complete activity: 2.0 hours

Fee: This lesson is offered free at www.pharmacytimes.org.

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-15-052-H01-P. The activity is available for CE credit through June 8, 2016.